期刊文献+

真空等离子喷涂HA/Ta复合涂层 被引量:6

Vacuum Plasma Spray Hydroxyapatite/Tantalum Composite Coatings
下载PDF
导出
摘要 羟基磷灰石(HA)具有良好的生物相容性和骨传导能力,采用等离子体喷涂技术在钛合金等金属基材上制备的HA涂层材料已在临床医学上被广泛使用。但是,HA涂层与钛合金基材之间较低的结合强度影响了植入物在体内的长期使用。本文采用真空等离子体技术制备钽(Ta)掺杂的HA涂层,以期在保持其良好生物学性能的同时提高其结合强度。HA/Ta复合涂层的微观形貌、元素组成和相组成由SEM及配套的能谱仪(EDS)和XRD分析技术表征。按ASTMC-633标准对涂层的结合强度进行了测试。将涂层试样浸泡于模拟体液中以评估其生物活性。结果表明:Ta增强HA涂层具有粗糙的表面和层状结构,其结合强度随着Ta含量的增加而增加。掺60%Ta(H4T6)涂层的结合强度达到37.2MPa,约为HA涂层的1.9倍。模拟体液浸泡试验显示,掺钽HA涂层表面形成了类骨磷灰石,表明具有良好的生物活性。 Plasma sprayed hydroxyapatite (HA) coating on titanium alloy substrate have been used extensively due to their excellent biocompatibility and osteoconductivity. However, the low bond strength between HA and Ti alloy is still problematic in the long-term implantation lifespan. In this paper, HA coatings with various Ta contents were fabricated by vacuum plasma spraying (VPS). The microstructure, chemical compositions and phase composition of the coatings were characterized by scanning electron microscopy (SEM) with an energy dispersive spectroscopy and X-ray diffraction (XRD). The coatings had a rough surface and lamellar structure including some pores. ASTM C-633 standard was used for the measurement of the bonding strength, which increased with increase of Ta contents in the composite coatings. The bonding strength of coating containing 60% Ta (H4T6) reached to about 37.2 MPa, was about 1.9 times higher than that of HA coating. In vitro bioactivity evaluated in simulated body fluids (SBF) results show that bonelike apatite layer was formed on the coatings surface, which indicated the good bioactivity for the Ta reinforced HA coatings and a potential candidate in implant surface modification.
出处 《热喷涂技术》 2013年第2期10-15,共6页 Thermal Spray Technology
关键词 羟基磷灰石涂层 钽涂层 结合强度 生物活性 真空等离子喷涂 HA coating Ta coating Bonding strength Bioactivity Vacuum plasma spray
  • 相关文献

参考文献5

二级参考文献27

  • 1[1]Hench L L, Anderson O. Bioactive glass [A]. In: Hench L L, Wilson J, eds. An introduction to bioceramics [M]. Singapore: World Scientific, 1993. 41-62.
  • 2[2]Hench L L, Wilson J. Surface-active Biomaterials [J]. Science, 1984, 226: 630-636.
  • 3[3]Hench L L, Paschall H A. Histo-chemical responses at a biomaterials interface [J]. J Biomed Mater Res, 1974, 5: 49-64.
  • 4[4]Merrollli A, Tranquilli L P, Guidi P L. Comparison in in vivo response between a bioactive glass and non-bioactive glass [J]. J Mater Sci Mater Med, 2000, 11: 219-222.
  • 5[5]Ohtsuki C, Kokubo T. Compositional dependence of bioactivity of glasses in the system CaO-SiO2-Al2O3: its in vitro evaluation [J]. J Mater Sci Mater Med 1992, 3: 119-125.
  • 6[6]Kokubo T, Ito S, Shigematsu M, et al. Fatigue and life time of bioactive glass-ceramic A-W containing apatite and wollastonite [J]. J Mater Sci, 1987, 22: 4 067-4 070.
  • 7[7]Kokubo T. Surface chemistry of bioactive glass-ceramics [J]. J Non-Cryst Solids, 1990, 120: 138-151.
  • 8[8]Ohtsuki C, Kokubo T, Yamamuro T. Mechanism of apatite formation on CaO-SiO2-P2O5 glasses in a simulated body fluid [J]. J Non-Cryst Solids, 1992, 143: 84-92.
  • 9[9]Hench L L, Anderson O. A/W glass-ceramic: processing and properties [A]. In: Hench L L, Wilson J, eds. An introduction to bioceramics [M]. Singapore: World Scientific, 1993. 75-88.
  • 10[10]De Aza P N, Guitian F, De Aza S. Bioactivity of wollastonite ceramics: in vitro evaluation [J]. Sripta Metall Mater, 1994, 31: 1 001-1 005.

共引文献60

同被引文献122

引证文献6

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部